par Zhang, H;He, J.;Kutateladze, Tatiana G;Sakai, Takahiro;Sasaki, Takehiko;Markadieu, Nicolas 
;Erneux, Christophe ;Prestwich, Glenn D
Référence ChemBioChem, 11, 3, page (388-395)
Publication Publié, 2010-02
;Erneux, Christophe ;Prestwich, Glenn DRéférence ChemBioChem, 11, 3, page (388-395)
Publication Publié, 2010-02
Article révisé par les pairs
| Résumé : | Metabolically stabilized analogues of PtdIns(3,4,5)P3 have shown long-lived agonist activity for cellular events and selective inhibition of lipid phosphatase activity. We describe an efficient asymmetric synthesis of two 5-phosphatase-resistant analogues of PtdIns(3,4,5)P3, the 5-methylene phosphonate (MP) and 5-phosphorothioate (PT). Furthermore, we illustrate the biochemical and biological activities of five stabilized PtdIns(3,4,5)P3 analogues in four contexts. First, the relative binding affinities of the 3-MP, 3-PT, 5-MP, 5-PT, and 3,4,5-PT3 analogues to the Grp1 PH domain are shown, as determined by NMR spectroscopy. Second, the enzymology of the five analogues is explored, showing the relative efficiency of inhibition of SHIP1, SHIP2, and phosphatase and tensin homologue deleted on chromosome 10 (PTEN), as well as the greatly reduced ability of these phosphatases to process these analogues as substrates as compared to PtdIns(3,4,5)P3. Third, exogenously delivered analogues severely impair complement factor C5a-mediated polarization and migration of murine neutrophils. Finally, the new analogues show long-lived agonist activity in mimicking insulin action in sodium transport in A6 cells. |
